Merck (Germany) Performance

MRK Stock  EUR 125.55  1.85  1.45%   
Merck has a performance score of 5 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.0511, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Merck are expected to decrease at a much lower rate. During the bear market, Merck is likely to outperform the market. Merck Company right now secures a risk of 1.34%. Please verify Merck Company potential upside, skewness, and the relationship between the maximum drawdown and semi variance , to decide if Merck Company will be following its current price movements.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Merck Company are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Merck is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Forward Dividend Yield
0.0173
Payout Ratio
0.3806
Last Split Factor
2:1
Forward Dividend Rate
2.2
Ex Dividend Date
2025-04-28
1
Merck Co., Inc. MRK Stock Holdings Boosted by Talbot Financial LLC - MarketBeat
12/19/2025
2
What Is Happening With Merck Stock - Trefis
01/08/2026
3
Merck Co., Inc. Shares Down 1.9 percent - Should You Sell - MarketBeat
01/16/2026
4
Is Merck Pricing Reflect Long Term Value After Recent Share Price Strength - Yahoo Finance
01/19/2026
5
Strs Ohio Boosts Stock Position in Merck Co., Inc. MRK - MarketBeat
01/23/2026
6
Merck Ends Acquisition Talks With Revolution Medicines After Valuation Dispute - Yahoo Finance
01/26/2026
7
Merck Co. Stock Outlook Is Wall Street Bullish or Bearish - Yahoo Finance
01/30/2026
8
Insider Sell Chirfi Guindo Sells 10,000 Shares of Merck Co In - GuruFocus
02/09/2026
9
Merck Creates Separate Cancer Business. The Stock Is Rising Ahead of Patent Cliff. - Barrons
02/23/2026
  

Merck Relative Risk vs. Return Landscape

If you would invest  11,990  in Merck Company on December 3, 2025 and sell it today you would earn a total of  565.00  from holding Merck Company or generate 4.71% return on investment over 90 days. Merck Company is currently producing 0.0869% returns and takes up 1.3358% volatility of returns over 90 trading days. Put another way, 12% of traded stocks are less volatile than Merck, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Merck is expected to generate 1.76 times more return on investment than the market. However, the company is 1.76 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.05 per unit of risk.

Merck Target Price Odds to finish over Current Price

The tendency of Merck Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 125.55 90 days 125.55 
about 30.19
Based on a normal probability distribution, the odds of Merck to move above the current price in 90 days from now is about 30.19 (This Merck Company probability density function shows the probability of Merck Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Merck Company has a beta of -0.0511. This indicates as returns on the benchmark increase, returns on holding Merck are expected to decrease at a much lower rate. During a bear market, however, Merck Company is likely to outperform the market. Additionally Merck Company has an alpha of 0.1757, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Merck Price Density   
       Price  

Predictive Modules for Merck

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Merck Company. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
124.16125.50126.84
Details
Intrinsic
Valuation
LowRealHigh
106.02107.36138.11
Details
Naive
Forecast
LowNextHigh
123.69125.02126.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.981.251.98
Details

Merck Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Merck is not an exception. The market had few large corrections towards the Merck's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Merck Company, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Merck within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.18
β
Beta against Dow Jones-0.05
σ
Overall volatility
4.49
Ir
Information ratio 0.08

Merck Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Merck for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Merck Company can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 55.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Merck Creates Separate Cancer Business. The Stock Is Rising Ahead of Patent Cliff. - Barrons

Merck Fundamentals Growth

Merck Stock prices reflect investors' perceptions of the future prospects and financial health of Merck, and Merck fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Merck Stock performance.

About Merck Performance

By analyzing Merck's fundamental ratios, stakeholders can gain valuable insights into Merck's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Merck has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Merck has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. MERCK Kommanditgesellschaft auf Aktien operates as a subsidiary of E. MERCK KGAA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 57850 people.

Things to note about Merck Company performance evaluation

Checking the ongoing alerts about Merck for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Merck Company help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 55.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Merck Creates Separate Cancer Business. The Stock Is Rising Ahead of Patent Cliff. - Barrons
Evaluating Merck's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Merck's stock performance include:
  • Analyzing Merck's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Merck's stock is overvalued or undervalued compared to its peers.
  • Examining Merck's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Merck's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Merck's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Merck's stock. These opinions can provide insight into Merck's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Merck's stock performance is not an exact science, and many factors can impact Merck's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins